Literature DB >> 16117636

Targeting dosage compensation to the X chromosome of Drosophila males.

H Oh1, X Bai, Y Park, J R Bone, M I Kuroda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16117636     DOI: 10.1101/sqb.2004.69.81

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


× No keyword cloud information.
  6 in total

Review 1.  The contradictory definitions of heterochromatin: transcription and silencing.

Authors:  Kathryn L Huisinga; Brent Brower-Toland; Sarah C R Elgin
Journal:  Chromosoma       Date:  2006-02-28       Impact factor: 4.316

2.  Chromosome-wide gene-specific targeting of the Drosophila dosage compensation complex.

Authors:  Gregor D Gilfillan; Tobias Straub; Elzo de Wit; Frauke Greil; Rosemarie Lamm; Bas van Steensel; Peter B Becker
Journal:  Genes Dev       Date:  2006-03-17       Impact factor: 11.361

3.  Role of the ATPase/helicase maleless (MLE) in the assembly, targeting, spreading and function of the male-specific lethal (MSL) complex of Drosophila.

Authors:  Rosa Morra; Ruth Yokoyama; Huiping Ling; John C Lucchesi
Journal:  Epigenetics Chromatin       Date:  2011-04-12       Impact factor: 4.954

4.  Targeting determinants of dosage compensation in Drosophila.

Authors:  Ina K Dahlsveen; Gregor D Gilfillan; Vladimir I Shelest; Rosemarie Lamm; Peter B Becker
Journal:  PLoS Genet       Date:  2006-02-03       Impact factor: 5.917

5.  Cumulative contributions of weak DNA determinants to targeting the Drosophila dosage compensation complex.

Authors:  Gregor D Gilfillan; Cornelia König; Ina K Dahlsveen; Nicky Prakoura; Tobias Straub; Rosemarie Lamm; Torsten Fauth; Peter B Becker
Journal:  Nucleic Acids Res       Date:  2007-05-05       Impact factor: 16.971

6.  Generation of a useful roX1 allele by targeted gene conversion.

Authors:  Manasi S Apte; Victoria A Moran; Debashish U Menon; Barbara P Rattner; Kathryn Hughes Barry; Rachel M Zunder; Richard Kelley; Victoria H Meller
Journal:  G3 (Bethesda)       Date:  2014-01-10       Impact factor: 3.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.